TLR3 and neoplasm: TLR3 genetic polymorphism also showed a trend to segregate patients with high risk from those who had low risk of relapsing after therapy, and the presence of the loss-of function allele (T) in homozygosity, which occurs in 8% of the global population, tended to correlate with a higher risk of tumor recurrence.